Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1572 | 2019 |
Orthotopic replacement of T-cell receptor α-and β-chains with preservation of near-physiological T-cell function K Schober, TR Müller, F Gökmen, S Grassmann, M Effenberger, ... Nature biomedical engineering 3 (12), 974-984, 2019 | 127 | 2019 |
Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 M Tenbusch, S Schumacher, E Vogel, A Priller, J Held, P Steininger, ... The Lancet Infectious Diseases 21 (9), 1212-1213, 2021 | 113 | 2021 |
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR D Stenger, TA Stief, T Kaeuferle, S Willier, F Rataj, K Schober, B Vick, ... Blood, The Journal of the American Society of Hematology 136 (12), 1407-1418, 2020 | 97 | 2020 |
The autoimmunity-associated gene CLEC16A modulates thymic epithelial cell autophagy and alters T cell selection C Schuster, KD Gerold, K Schober, L Probst, K Boerner, MJ Kim, ... Immunity 42 (5), 942-952, 2015 | 94 | 2015 |
Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection K Schober, F Voit, S Grassmann, TR Müller, J Eggert, S Jarosch, ... Nature immunology 21 (4), 434-441, 2020 | 82 | 2020 |
Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination P Irrgang, J Gerling, K Kocher, D Lapuente, P Steininger, K Habenicht, ... Science immunology 8 (79), eade2798, 2022 | 73 | 2022 |
T cell engineering for adoptive T cell therapy: safety and receptor avidity E D’Ippolito, K Schober, M Nauerth, DH Busch Cancer Immunology, Immunotherapy 68 (10), 1701-1712, 2019 | 42 | 2019 |
Skin and gut imprinted helper T cell subsets exhibit distinct functional phenotypes in central nervous system autoimmunity M Hiltensperger, E Beltrán, R Kant, S Tyystjärvi, G Lepennetier, ... Nature immunology 22 (7), 880-892, 2021 | 40 | 2021 |
Early emergence of T central memory precursors programs clonal dominance during chronic viral infection S Grassmann, L Mihatsch, J Mir, A Kazeroonian, R Rahimi, ... Nature immunology 21 (12), 1563-1573, 2020 | 39 | 2020 |
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma E Gaitzsch, V Passerini, E Khatamzas, CD Strobl, M Muenchhoff, ... Hemasphere 5 (7), 2021 | 38 | 2021 |
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®) J Held, J Esse, K Tascilar, P Steininger, K Schober, P Irrgang, ... Vaccines 9 (10), 1063, 2021 | 33 | 2021 |
TCR repertoire evolution during maintenance of CMV‐specific T‐cell populations K Schober, VR Buchholz, DH Busch Immunological reviews 283 (1), 113-128, 2018 | 33 | 2018 |
Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy TR Müller, S Jarosch, M Hammel, J Leube, S Grassmann, B Bernard, ... Cell Reports Medicine 2 (8), 2021 | 29 | 2021 |
Inventories of naive and tolerant mouse CD4 T cell repertoires reveal a hierarchy of deleted and diverted T cell receptors T Hassler, E Urmann, S Teschner, C Federle, T Dileepan, K Schober, ... Proceedings of the National Academy of Sciences 116 (37), 18537-18543, 2019 | 27 | 2019 |
CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients S Weber, V Kehl, J Erber, KI Wagner, AM Jetzlsperger, T Burrell, ... PLoS One 17 (5), e0268530, 2022 | 25 | 2022 |
Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’ DS Fischer, M Ansari, KI Wagner, S Jarosch, Y Huang, CH Mayr, M Strunz, ... Nature communications 12 (1), 4515, 2021 | 25 | 2021 |
Systematic identification of cancer-specific MHC-binding peptides with RAVEN MC Baldauf, JS Gerke, A Kirschner, F Blaeschke, M Effenberger, ... Oncoimmunology 7 (9), e1481558, 2018 | 23 | 2018 |
FLEXamers: a double tag for universal generation of versatile peptide-MHC multimers M Effenberger, A Stengl, K Schober, M Gerget, M Kampick, TR Müller, ... The Journal of Immunology 202 (7), 2164-2171, 2019 | 21 | 2019 |
Cytomegalovirus vector expressing RAE‐1γ induces enhanced anti‐tumor capacity of murine CD8+ T cells T Tršan, K Vuković, P Filipović, AL Brizić, NAW Lemmermann, K Schober, ... European journal of immunology 47 (8), 1354-1367, 2017 | 20 | 2017 |